Medtronic (BSP:MDTC34) Other Current Liabilities: R$13,481 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:MDTC34 Medtronic PLC BSP:MDTC34
72 GF Score
Price R$212.73
GF Value R$247.49
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medtronic Other Current Liabilities?

Medtronic BSP:MDTC34 72 Other Current Liabilities is R$13,481 Mil as of Apr. 2026. GuruFocus rates BSP:MDTC34 with a GF Score™ of 72/100 and a GF Value™ of R$247.49 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Medtronic's other current liabilities for the quarter that ended in Apr. 2026 was R$13,481 Mil.

Medtronic's quarterly other current liabilities increased from Oct. 2025 (R$11,472 Mil) to Jan. 2026 (R$13,761 Mil) but then declined from Jan. 2026 (R$13,761 Mil) to Apr. 2026 (R$13,481 Mil).

Medtronic's annual other current liabilities increased from Apr. 2024 (R$12,184 Mil) to Apr. 2025 (R$14,563 Mil) but then declined from Apr. 2025 (R$14,563 Mil) to Apr. 2026 (R$13,481 Mil).

Medtronic Other Current Liabilities Related Terms

Medtronic Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Medtronic's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic Other Current Liabilities Chart

Medtronic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,084.72 9,781.88 12,183.75 14,563.11 13,480.78

Medtronic Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,563.11 11,154.93 11,471.60 13,760.86 13,480.78
BSP:MDTC34
72GF Score
Medtronic PLC BSP:MDTC34
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtronic Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of R$13,481 Mil mean?
Medtronic (BSP:MDTC34) has a Other Current Liabilities of R$13,481 Mil as of Apr. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Medtronic.
Is Medtronic's Other Current Liabilities too high?
Medtronic's current Other Current Liabilities is R$13,481 Mil. Overall, Medtronic has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Other Current Liabilities compare to SYK and BSX?
Medtronic's Other Current Liabilities of R$13,481 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Medtronic. Medtronic's current Other Current Liabilities is R$13,481 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (BSP:MDTC34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$247.49, compared to a current price of R$212.73 — trading 14% below its estimated fair value. The current Other Current Liabilities is R$13,481 Mil. Medtronic's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Medtronic (BSP:MDTC34), the current Other Current Liabilities is R$13,481 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtronic (BSP:MDTC34) Overvalued in 2026?

Based on GuruFocus' analysis, Medtronic stock appears to be undervalued. The current stock price of R$212.73 is trading 14% below its estimated GF Value™ of R$247.49. GuruFocus considers Medtronic to be Modestly Undervalued.

Key valuation signals for BSP:MDTC34:

  • Other Current Liabilities: R$13,481 Mil
  • GF Value™: R$247.49 vs. price of R$212.73 (14% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the BSP:MDTC34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medtronic Business Description

Address Parkmore Business Park West, Building Two, Galway, IRL
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
72GF Score

Get the complete analysis for BSP:MDTC34

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$212.73
Price
R$247.49
GF Value